Baillie Gifford & CO Codexis, Inc. Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
A detailed history of Baillie Gifford & CO transactions in Codexis, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,685,664 shares of CDXS stock, worth $4.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,685,664
Previous 1,699,644
0.82%
Holding current value
$4.94 Million
Previous $4.57 Million
10.04%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
66.9MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$27.8 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$23.7 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$13.8 Million0.0% of portfolio
-
Abrdn PLC4.2MShares$12.3 Million0.02% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $192M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...